Pharmacological rationale for the clinical use of paracetamol:: Pharmacokinetic and pharmacodynamic issues

被引:54
作者
Bannwarth, B [1 ]
Péhourcq, F
机构
[1] Grp Hosp Pellegrin, Serv Rheumatol, F-33076 Bordeaux, France
[2] Univ Victor Segalen, Lab Therapeut, Serv Rheumatol, EA 525, Bordeaux, France
[3] Univ Victor Segalen, Pharmacol Lab, Bordeaux, France
关键词
D O I
10.2165/00003495-200363992-00003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The advantage of paracetamol (acetaminophen) is that it can be administered via the oral, intravenous or rectal routes. The last mentioned differs from the oral route in the slow and irregular absorption of the active substance. At therapeutic concentrations, the pharmacokinetics of paracetamol are linear - that is, independent of the dose, and constant with repeated administration. The efficacy of paracetamol has been demonstrated in a wide variety of acute or chronic painful syndromes. In adults, the optimum unit dose is 1g. The maximum daily dosage is 4g, consistent with the decline in analgesic activity, which is usually over 6 hours. With effervescent tablets, drug absorption and onset of action are more rapid than with conventional tablets. However, there is no direct correlation between serum concentrations of paracetamol and its analgesic or antipyretic effect. Paracetamol is the non-opiate analgesic of choice in elderly persons or patients with chronic renal insufficiency, and it is usually not necessary to reduce the dosage in such individuals, even though clearance is reduced. Although the bioavailability of paracetamol is not impaired in patients with chronic, benign liver diseases, the agent is contraindicated in those with hepatic insufficiency. It can be used during pregnancy and lactation. The very low level of paracetamol binding to plasma proteins, together with its hepatic metabolism, mainly through glucuronide or sulphate conjugation, account for the low risk of drug interactions with paracetamol, particularly with antivitamin K. When added to a traditional non-steroidal anti-inflammatory drug, paracetamol enhances the analgesic effect or allows the use of lower doses. It is more difficult to define the ideal dosage of paracetamol in children, because of the influence of age on its pharmacokinetics, and the relatively erratic bioavailability of suppositories. An oral dose of 15 mg/kg every 4 hours, up to a total of 60 mg/kg/day, is usually sufficient to achieve the desired analgesic or antipyretic effect.
引用
收藏
页码:5 / 13
页数:9
相关论文
共 41 条
[1]  
*AG FRANC SEC SAN, 2001, PRESSE MED, V30, P325
[2]   Metabolism of paracetamol in children with chronic liver disease [J].
AlObaidy, SS ;
McKiernan, PJ ;
Po, ALW ;
Glasgow, JFT ;
Collier, PS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1996, 50 (1-2) :69-76
[3]   Rectal paracetamol dosing regimens: determination by computer simulation [J].
Anderson, BJ ;
Holford, NHG .
PAEDIATRIC ANAESTHESIA, 1997, 7 (06) :451-455
[4]   A model for size and age changes in the pharmacokinetics of paracetamol in neonates, infants and children [J].
Anderson, BJ ;
Woollard, GA ;
Holford, NHG .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2000, 50 (02) :125-134
[5]   Perioperative pharmacodynamics of acetaminophen analgesia in children [J].
Anderson, BJ ;
Holford, NHG ;
Woollard, GA ;
Kanagasundaram, S ;
Mahadevan, M .
ANESTHESIOLOGY, 1999, 90 (02) :411-421
[6]   PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF PARACETAMOL AFTER A SINGLE INTRAVENOUS DOSE OF PROPACETAMOL [J].
BANNWARTH, B ;
NETTER, P ;
LAPICQUE, F ;
GILLET, P ;
PERE, P ;
BOCCARD, E ;
ROYER, RJ ;
GAUCHER, A .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1992, 34 (01) :79-81
[7]  
Bannwarth B, 2001, J RHEUMATOL, V28, P182
[8]  
BEAULACBAILLARGEON L, 1994, EUR J CLIN PHARMACOL, V46, P451
[9]   The pharmacokinetics and analgesic efficacy of larger dose rectal acetaminophen (40 mg/kg) in adults: A double-blinded, randomized study [J].
Beck, DH ;
Schenk, MR ;
Hagemann, K ;
Doepfmer, UR ;
Kox, WJ .
ANESTHESIA AND ANALGESIA, 2000, 90 (02) :431-436
[10]   Twenty-four-hour pharmacokinetics of rectal acetaminophen in children - An old drug with new recommendations [J].
Birmingham, PK ;
Tobin, MJ ;
Henthorn, TK ;
Fisher, DM ;
Berkelhamer, MC ;
Smith, FA ;
Fanta, KB ;
Cote, CJ .
ANESTHESIOLOGY, 1997, 87 (02) :244-252